Prion disease associated neurotoxicity is mainly attributed to PrP-scrapie (PrP Sc ), the disease associated isoform of a normal protein, the prion protein (PrP C ). Participation of other proteins and processes is suspected, but their identity and contribution to the pathogenic process is unclear. Emerging evidence implicates imbalance of brain iron homeostasis as a significant cause of prion disease-associated neurotoxicity. The underlying cause of this change, however, remains unclear. We demonstrate that iron is sequestered in heat and SDSstable protein complexes in sporadic-Creutzfeldt-Jakob-disease (sCJD) brains, creating a phenotype of iron deficiency. The underlying cause is change in the characteristics of ferritin, an iron storage protein that becomes aggregated, detergent-insoluble, and partitions with denatured ferritin using conventional methods of ferritin purification. A similar phenotype of iron deficiency is noted in the lumbar spinal cord (SC) tissue of scrapie infected hamsters, a site unlikely to be affected by massive neuronal death and non-specific iron deposition. As a result, the iron uptake protein transferrin (Tf) is upregulated in scrapie infected SC tissue, and increases with disease progression. A direct correlation between Tf and PrP Sc suggests sequestration of iron in dysfunctional ferritin that either co-aggregates with PrP Sc or is rendered dysfunctional by PrP Sc through an indirect process. Surprisingly, amplification of PrP Sc in vitro by the protein-misfolding-cyclic-amplification (PMCA) reaction using normal brain homogenate as substrate does not increase the heat and SDS-stable pool of iron even though both PrP Sc and ferritin aggregate by this procedure. These observations highlight important differences between PrP Sc -protein complexes generated in vivo during disease progression and in vitro by the PMCA reaction, and the significance of these complexes in PrP Sc -associated neurotoxicity.
Introduction
Sporadic Creutzfeldt-Jakob disease (sCJD) is a progressive, fatal neurodegenerative condition of humans that is included in the general category of prion disorders. Unlike most neurodegenerative conditions, prion disorders are transmissible in addition to their sporadic and familial nature, a characteristic that has raised significant public health concern. sCJD is the most common human prion disorder, comprising~80% of all diagnosed cases. The infectious and pathogenic agent in all prion disorders is believed to be PrP-scrapie (PrP Sc ), a β-sheet rich isoform of a normal protein, the prion protein (PrP C ).
The conformational switch from PrP C to PrP Sc is triggered by exogenous PrP Sc in transmissible disorders, mutation in the prion protein gene in familial cases, and by a random event in sporadic disorders. Unlike PrP C that is mainly α-helical, soluble in non-ionic detergents and sensitive to proteases, PrP Sc requires harsh conditions such as sodium dodecyl sulfate (SDS) or guanidinium hydrochloride treatment for complete solubilization, and is resistant to limited digestion by proteinase K (PK) (Aguzzi and Calella, 2009; Caughey et al., 2009; Prusiner, 1998; Soto and Satani, 2010 (Chesebro et al., 2005; Mallucci et al., 2007; Radford and Mallucci, 2010) . Contribution of other proteins and molecules, though speculated, has remained elusive (Resenberger et al., 2011) . Recent reports indicating mis-regulation of iron metabolism in sCJD and scrapie infected animal brains implicate redox-iron in prion disease pathogenesis, an important observation given the highly toxic nature of unliganded iron and its documented involvement in other neurodegenerative conditions of protein misfolding such as Alzheimer's disease (AD), Parkinson's disease, and Huntington's 
